Non-Invasive Respiratory Monitoring to Predict Successful Separation From Mechanical Ventilation Following Upper Abdominal Surgery

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPapawee Chennavasin

About this trial

The VALUE Study is a two-phase, prospective clinical trial conducted at King Chulalongkorn Memorial Hospital (KCMH). The study evaluates the prevalence of mechanical ventilation (MV) separation failure in post-open upper abdominal surgery patients and investigates whether non-invasive bedside respiratory monitoring tools can rapidly predict extubation failure.

The protocol focuses on Electrical Impedance Tomography (EIT) metrics-specifically regional ventilation distribution and the absolute ventral-to-dorsal difference-alongside ventilator-derived measures of respiratory drive. It also tracks physiological responses and clinical outcomes, including dyspnea using the Intensive Care Respiratory Distress Observation Scale (IC-RDOS) and the ROX index, across standard post-extubation oxygen delivery methods (nasal cannula vs. High-Flow Nasal Cannula \[HFNC\]).

Eligibility criteria

Qualifiers

Age of ≥ 18 years

Post elective open upper abdominal surgery with mechanical ventilation

Get readiness for mechanical ventilation weaning with pressure support 5-8 cmH2O and PEEP 5-8 cmH2O set by clinical team and prompt extubation assessed by clinical team

Disqualifiers

Previous tracheostomy

Contraindication to EIT placement: pacemaker/defibrillator implantation, burns at the area of EIT placement

Patient with end-of-life plan

Emergency operation

Trial design

Treatments tested in this trial

  • High Flow Oxygen
  • Nasal canula oxygen

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators

Papawee Chennavasin

Lead sponsor

King Chulalongkorn Memorial Hospital

Sponsor institution